Search results :

Fesoterodine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: G04BD11

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Dry mouth Dry mouth 18.8% - 34.6% 7% x x x x x
Constipation Constipation 4.2% - 6% 2% x x x x x
Urinary tract infection Urinary tract infection 3.2% - 4.2% 3.1% x x x x x
Dry eye Dry eye 1.4% - 3.7% 0% x x x x x
Upper respiratory tract infection Upper respiratory tract infection 1.8% - 2.5% 2.2% x x x x
Dyspepsia Dyspepsia 1.6% - 2.3% 0.5% x x x x x
Dry throat Dry throat 0.9% - 2.3% 0.4% x x x x
Back pain Back pain 0.9% - 2% 0.4% x x x x
Dysuria Dysuria 1.3% - 1.6% 0.7% x x x x x
Nausea Nausea 0.7% - 1.9% 1.3% x x x x x
Cough Cough 0.9% - 1.6% 0.5% x x x x
Dry cough x
Urinary retention Urinary retention 1.1% - 1.4% 0.2% x x x x x
Feeling of residual urine x
Oedema peripheral Oedema peripheral 0.7% - 1.2% 0.7% x x x x
Dermatitis Rash 0.7% - 1.1% 0.5% x x x x x
Rash Rash 0.7% - 1.1% 0.5% x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased 0.5% - 1.2% 0.9% x x x x x
Insomnia Insomnia 0.4% - 1.3% 0.5% x x x x x
Gamma-glutamyltransferase increased Gamma-glutamyltransferase increased 0.4% - 1.2% 0.4% x x x x x
Abdominal pain upper Abdominal pain upper 0.5% - 1.1% 0.5% x x x x
Obstructive airways disorder Airway obstruction NOS postmarketing x x x
Angioedema Angioedema postmarketing x x x x
Nervous system disorder Central nervous system disorder postmarketing x x
Nervous system disorder x
Dizziness Dizziness postmarketing x x x
Eye disorder Eye disorder postmarketing 0% x x x x x
Headache Headache postmarketing x x x
Cardiac disorder Cardiac disorder postmarketing x x x x
Hypersensitivity Hypersensitivity postmarketing x x x
Palpitations Palpitations postmarketing x x x x
Pruritus Pruritus postmarketing x x x x
Urticaria Urticaria postmarketing x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x
Skin disorder 0.5% x x x x
Vision blurred Vision blurred postmarketing x x x x
Face oedema Face oedema postmarketing x x x
Somnolence Somnolence postmarketing x x x
Abdominal pain Abdominal pain x x x x x
Gastrointestinal pain Abdominal pain x x x x x
Angina pectoris Angina pectoris x x x x
Mental disorder Mental disorder 0.5% x x x x x
Chest pain Chest pain x x x x
Infection Infection 3.1% x x x x x
Confusional state Confusional state x
Feeling abnormal Confusional state x
Diarrhoea Diarrhoea x
Diverticulitis Diverticulitis x x x x
Dysgeusia Dysgeusia x
Asthenia Fatigue x
Fatigue Fatigue x
Flatulence Flatulence x
Gastroenteritis Gastroenteritis x x x x
Gastrooesophageal reflux disease Gastrooesophageal reflux disease x
Gastrointestinal disorder Gastrointestinal disorder x x x x x
Irritable bowel syndrome Irritable bowel syndrome x x x x
Functional gastrointestinal disorder Irritable bowel syndrome x x x x
Mediastinal disorder Mediastinal disorder x
Musculoskeletal disorder Musculoskeletal disorder 0.4% x x x x
Tachycardia Tachycardia x
Micturition disorder Micturition disorder x
Urethral disorder Urinary tract disorder x x x x x
Urinary tract disorder Urinary tract disorder x x x x x
Vertigo Vertigo x
Dry skin Dry skin x
Urinary hesitation Urinary hesitation x
Nasal dryness Nasal dryness x
Abdominal discomfort Abdominal discomfort x
Hepatic enzyme increased Hepatic enzyme increased x
Hepatobiliary disease Hepatobiliary disease x
Infestation Infestation NOS x
Electrocardiogram QT interval Electrocardiogram QT corrected interval x x x x
Laryngeal pain Pharyngolaryngeal pain x
Benign prostatic hyperplasia Benign prostatic hyperplasia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

FESOTERODINE FUMARATE / TOVIAZ

Side effects:31
Source:FDA

fesoterodine

Side effects:42
Source:FDA Structured Product Label

FESOTERODINE

Side effects:46
Source:FDA Structured Product Label

FESOTERODINE

Side effects:46
Source:FDA Structured Product Label

fesoterodine / fesoterodine fumarate

Side effects:52
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label